medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2020, Number 12

<< Back Next >>

Ginecol Obstet Mex 2020; 88 (12)

Intrauterine tamponade with hydrostatic balloons: A narrative review

Robles-Elías FJ, Meade-Treviño P, Fernández-Lara JA, Robles-Morales R

Language: Spanish
References: 85
Page: 870-889
PDF size: 377.72 Kb.


ABSTRACT

Objective: Evaluate de effectiveness of uterine balloons tamponade methods, based on the outcomes of literature reports regarding clinical results, variety, advantages and disadvantages, as to the indications and particularities that is offered by its use.
Methodology: Narrative study of articles indexed in PubMed, Medline, SciELO, and Google Scholar, in English and Spanish language, published between 2008 and April 2020 that contain in their title the keyword postpartum hemorrhage (MeSH) associated with uterine tamponade with hydrostatic balloon, Bakri balloon and uterine atony.
Results: 10,984 articles where identified with the key word “obstetric hemorrhage”, when associated with “intrauterine tamponade” they were reduced to 471 references with the final inclusion of 85 after fulfilling the requirements of the authors and 386 articles were excluded.
Conclusions: The use of intrauterine tamponade devices with hydrostatic balloons, due to their high clinical efficiency, accessible cost, easy application, minimal complications, and scarce contraindications, should be a part the management protocols and always be available in all the different scenarios of obstetrical resolution, preserving its primary indication in persistent uterine atony, but expanding the possibilities of its use on placental bed bleeding, placenta previa, and in cases of specific placental acretism with segmental infiltration. It should be considered as a therapeutically approach, earlier post obstetrical event, as in the case of the first uterotonic agent failure, and in selected cases of high-risk for obstetric hemorrhage as a prophylactic procedure.


REFERENCES

  1. Global, regional and national age-sex specific mortality for 282 causes of death in 195 countries and territories. 1980- 2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1736-88. DOI: http:// doi.org/10.1016/SO140-6736(18)32203-7

  2. Observatorio de Mortalidad Materna en México. Indicadores de mortalidad materna.http://www.omm.org.mx/ index.php/indicadores-nacionales/indicadores.

  3. Fernandez-Lara JA, Toro-Ortiz C. Tasa de hemorragia, histerectomía obstétrica y muerte materna relacionada. Ginecol Obstet Mex. 2017;85(4):247-253. https://ginecologiayobstetricia. org.mx/secciones/articulos-originalesnumero83/ tasa-de-hemorragia-histerectomia-obstetrica-y-muertematerna- relacionada/

  4. Trejo-Romero JC, Reyes-Hernández MU, et al. Sutura compresiva invaginante para control de la hemorragia obstétrica. Ginecol Obstet Mex 2017;85(8):498-503. https://ginecologiayobstetricia. org.mx/secciones/editorial/sutura-compresiva- invaginante-para-control-de-la-hemorragia-obstetrica/

  5. Bateman BT, Berman MF. The Epidemiology of Postpartum Hemorrhage in a Large, Nationwide Sample of Deliveries. Anesth Analg 2018110(5):1368-1373. doi: 10.1213/ ane.0b013e3181d74898

  6. Oyelese Y, Ananth C. Postpartum Hemorrhage: Epidemiology, Risk Factors, and Causes. Clin Obstet Gynecol 2010;53(1):147-156. doi: 10.1097/grf.0b013e3181cc406d

  7. Clark S, Belfort M. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol 2008;199(1):36.e1-36.e5. doi: 10.1016/j. ajog.2008.03.007

  8. Berg C, Harper M. Preventability of pregnancy-related deaths. Obstet Gynecol 2005;106(6):1228-1234. doi: 10.1097/01.aog.0000187894.71913.e8

  9. Rousseau A, Rozenberg P. Variation in severe postpartum hemorrhage management: A national vignette-based study. PLoS One 2018;13(12):e029074. doi: 10.1371/journal. pone.0209074

  10. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum hemorrhage. Obstet Gynecol 2017;130:e168-86. doi: 10.1097/AOG.0000000000002351.

  11. Clark SL, Hankins GDV. Obstetrics: A Text-book for the Use of Students and Practitioners. Operative Porcedures Wicho Do Not Aim At Delivery. 1st ed. Conneticut: Appleton & amp, 1997.

  12. Smith WC. Uterine tamponade with oxidized gauze in a case of total separation of the placenta with concealed hemorrhage. N Y State J Med. 1949;49(18):2187.

  13. Bakri Y, B-Lynch C. Second generation of intrauterine balloon tamponade: new perspective. BMJ Innovations 2020;6(1):1-3. doi: 10.1136/bmjinnov-2019-000404

  14. Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG 2009;116(6):748- 757. doi: 10.1111/j.1471-0528.2009.02113.x .

  15. Belfort AM, Dildy GA. Intraluminal pressure in a uterine tamponade balloon is curvilinearly related to the volume of fluid infused. Am J Perinatol 2011;28(08):659-666. doi: 10.1055/s-0031-1276741

  16. Holtz RS. The control of postpartum hemorrhage by the intrauterine balloon. Am J Obstet Gynecol 1951;62(2):450- 451. doi: 10.1016/0002-9378(51)90546-7

  17. Bakri Y, Amri A. Tamponade-balloon for obstetrical bleeding. Int J Gynecol Obstet 2001;74(2):139-142. doi: 10.1016/s0020-7292(01)00395-2

  18. Georgiou C. A review of current practice in using Balloon Tamponade Technology in the management of postpartum haemorrhage. Hyperten Res Preg 2014;2(1):1-10. doi: 10.14390/jsshp.2.1

  19. De la Luna y Olsen E, Carranza-Sánchez B, et al. Experiencia con el balón de Bakri en hemorragia obstétrica. Ginecol Obstet Mex 2017;85(11):719-726. DOI: https:// doi.org/10.24245/gom.v85i11.1345

  20. Chan C, Razvi K. The use of a Sengstaken-Blakemore tube to control post-partum hemorrhage. Int J Gynecol Obstet 1997;58(2):251-252. doi: 10.1016/s0020- 7292(97)00090-8

  21. Rathore AM, Gupta S. Uterine tamponade using condom catheter balloon in the management of nontraumatic postpartum hemorrhage. J Obstet Gynaecol Res 2012;38(9):1162-1167. doi: 10.1111/j.1447- 0756.2011.01843.x

  22. Burke T, Ahn R. A postpartum haemorrhage package with condom uterine balloon tamponade: a prospective multicentre case series in Kenya, Sierra Leone, Senegal, and Nepal. BJOG 2015;123(9):1532-1540. doi: 10.1111/1471- 0528.13550

  23. Herrick T, Mvundura M. A low-cost uterine balloon tamponade for management of postpartum hemorrhage: modeling the potential impact on maternal mortality and morbidity in sub-Saharan Africa. BMC Pregnancy Childbirth 2017;17(1). doi: 10.1186/s12884-017-1564-5

  24. Makin J, Suarez-Rebling DI. Innovative Uses of Condom Uterine Balloon Tamponade for Postpartum Hemorrhage in India and Tanzania. Case Rep Obstet Gynecol 2018;2018:4952048. doi: 10.1155/2018/4952048

  25. Ramanathan A, Eckardt MJ. Safety of a condom uterine balloon tamponade (ESM-UBT) device for uncontrolled primary postpartum hemorrhage among facilities in Kenya and Sierra Leone. BMC Pregnancy Childbirth. 2018;18:168. doi.org/10.1186/s12884-018-1808-z

  26. Diemert A, Ortmeyer G. The combination of intrauterine balloon tamponade and the B-Lynch procedure for the treatment of severe postpartum hemorrhage. Am J Obstet Gynecol 2012; 206(1):65.e1–65.e4. doi: 10.1016/j. ajog.2011.07.041

  27. Mavrides E, Allard S. AJ on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. BJOG 201;124:e106-e149. https://ranzcog.edu.au/RANZCOG_SITE/media/RANZCOGMEDIA/ Women%27s%20Health/Statement%20and%20 guidelines/Clinical-Obstetrics/RCOG-Prevention-and-Management- of-Postpartum-Haemorrhage-2016.pdf?ext=.pdf

  28. Sentilhes L, Vayssière C, et al. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Instensive Care (SFAR). Eur J Obstet Gynecol Reprod Biol 2016;198:12- 21. doi: 10.1016/j.ejogrb.2015.12.012

  29. Wang D, Xu S. Early usage of Bakri postpartum balloon in the management of postpartum hemorrhage: a large prospective, observational multicenter clinical study in South China. J Perinatal Med 2018;46(6):649-656. doi: 10.1515/jpm-2017-0249

  30. Wright CE, et al. Bakri ballon in the management of postpartum hemorrhage: A review. Am J Perinatol 2014;31(11):957-964. doi: 10.1055/s-0034-1372422

  31. Alkış İ, et al. The fertility sparing management of postpartum hemorrhage: A series of 47 cases of Bakri balloon tamponade. Taiwan J Obstet Gynecol 2015;54(3):232-235. doi: 10.1016/j.tjog.2014.03.009

  32. Kong CW, et al. Prognostic factors for the use of intrauterine balloon tamponade in the management of severe postpartum hemorrhage. Int J Gynecol Obstet 2018;142(1):48- 53. doi: 10.1002/ijgo.12498

  33. Brown H, Okeyo S. The Bakri tamponade balloon as an adjunct treatment for refractory postpartum hemorrhage. Int J Gynecol Obstet 2016;135(3):276-280. doi: 10.1016/j. ijgo.2016.06.021

  34. Cho HY, Park YW. Efficacy of Intrauterine Bakri Balloon Tamponade in Cesarean Section for Placenta Previa Patients. PLoS One. 2015:10(8):e0134282. doi: 10.1371/journal. pone.0134282

  35. Pillarisettya LS, Thaia T. Postpartum Hemorrhage: Use of Bakri Balloon During Cesarean Delivery, a Case Report and Review. J Clin Gynecol Obstet. 2019;8(2):57-61 doi: https:// doi.org/10.14740/jcgo556

  36. McQuivey RW, Block J. E. ebb® Complete Tamponade System: effective hemostasis for postpartum hemorrhage. Med Devices 2018:11:57-63. doi: 10.2147/MDER.S158944

  37. Uygur D, Altun-Ensari T, et al. Successful use of BT-Cath® balloon tamponade in the management of postpartum haemorrhage due to placenta previa. Eur J Obstet Gynecol Reprod Biol 2014:181:223-228. doi: 10.1016/j. ejogrb.2014.08.002

  38. Purwosunu Y, Sarkoen W. Control of Postpartum Hemorrhage Using Vacuum-Induced Uterine Tamponade. Obstet Gynecol 2016;128(1):33-36. doi: 10.1097/ aog.0000000000001473

  39. Albayrak M, Ozdemir I. Post-partum haemorrhage from the lower uterine segment secondary to placenta praevia/accreta: Successful conservative management with Foley balloon tamponade. Aust N Z J Obstet Gynaecol 2011;51(4):377- 380. doi: 10.1111/j.1479-828x.2011.01309.x

  40. Soon R, Aeby T. Cesarean scar dehiscence associated with intrauterine balloon tamponade placement after a second trimester dilation and evacuation. Hawaii Med J 2011;70(7):137-8.

  41. Ajayi O, Manjusha S. Uterine rupture complicating sequential curettage and Bakri balloon tamponade to control secondary PPH. BMJ Case Rep 2013;6. doi: 10.1136/ bcr-2012-007709.

  42. Leparco S, Viot A. Migration of Bakri balloon through an unsuspected uterine perforation during the treatment of secondary postpartum hemorrhage. Am J Obstet Gynecol 2013;208(6):e6-e7. doi: 10.1016/j.ajog.2013.02.052

  43. Suarez S, Conde-Agudelo A. Uterine Balloon Tamponade for the Treatment of Postpartum Hemorrhage: a Systematic Review and Meta-Analysis. Am J Obstet Gynecol 2020;222(4):293.e1-293.e52. doi: 10.1016/j. ajog.2019.11.1287

  44. Nagase Y, Matsuzaki S. Efficacy of Prophylactic Antibiotics in Bakri Intrauterine Balloon Placement: A Single-Center Retrospective Analysis and Literature Review. Am J Perinatol Rep 2020;10(01):e106-e112. doi: 10.1055/s-0040- 1708487

  45. Georgiou C. Intraluminal pressure readings during the establishment of a positive “tamponade test” in the management of postpartum haemorrhage. BJOG 2009;117(3):295- 303. doi: 10.1111/j.1471-0528.2009.02436.x

  46. Racusin D, Belfort M. Under Pressure: Intraluminal Filling Pressures of Postpartum Hemorrhage Tamponade Balloons. Am J Perinatol Rep 2017;(02):e86-e92. doi: 10.1055/s-0037-1602657

  47. Einerson B, Schneider P. Is There an Association Between Indication for Intrauterine Balloon Tamponade and Balloon Failure? Am J Perinatol 2017;34(02):164-168. doi: 10.1055/s-0036-1585084 .

  48. Kondoh E, Chigusa Y. Novel intrauterine balloon tamponade systems for postpartum hemorrhage. Acta Obstet Gynecol Scand 2019;00:1-6. doi: 10.1111/aogs.13692

  49. Ogoyama M, Takahashi H. Hemostatic effect of intrauterine balloon for postpartum hemorrhage with special reference to concomitant use of “holding the cervix” procedure (Matsubara). Eur J Obstet Gynecol Reprod Biol 2017;210:281- 285. doi: 10.1016/j.ejogrb.2017.01.012

  50. Kong C, To W. Intraluminal pressure of uterine balloon tamponade in the management of severe post-partum hemorrhage. J Obstet Gynaecol Res 2018;44(5):914-921. doi: 10.1111/jog.13596

  51. Revert M, Cottenet J. Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study. BJOG 2016;124(8):1255-1262. doi: 10.1111/1471-0528.14382

  52. Olsen R, Reisner D. Bakri balloon effectiveness for postpartum hemorrhage: a “real world experience.” J Matern Fetal Neonatal Med 2013;26(17):1720-1723. doi: 10.3109/14767058.2013.796354

  53. Tindell K, Garfinkel R. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. BJOG 2012;120(1):5-14. DOI: 10.1111/j.1471-0528.2012.03454.x

  54. Burke TF, Danso-Bamfo S. Shock progression and survival after use of a condom uterine balloon tamponade package in women with uncontrolled postpartum hemorrhage. Int J Gynecol Obstet 2017;139(1):34-38. doi:10.1002/ijgo.12251

  55. Sandoval García-Travesí F, Hinojosa-Cruz J. Tratamiento de la hemorragia posparto con condón hidrostático intrauterino. Ginecol Obstet Mex 2016;84(4):243-251. https:// ginecologiayobstetricia.org.mx/secciones/articulos-originales- numero83/tratamiento-la-hemorragia-pospartocondon- hidrostatico-intrauterino/

  56. Cruz-Cruz D, Peña-Dehesa H. Tratamiento activo de la hemorragia posparto y colocación del balón de Bakri en primigestas y multigestas. Ginecol Obstet Mex 2016;84(5):279-286. https://ginecologiayobstetricia.org. mx/secciones/articulos-originales-numero83/tratamientoactivo- la-hemorragia-posparto-colocacion-del-balonbakri- pacientes-primigestas-multigestas/

  57. Reynosa-Oviedo Y, López-Vera E. Eficacia y seguridad del taponamiento uterino para control de hemorragia y disminución de histerectomía obstétrica. Cohorte histórica en Nuevo León, México. Rev Colomb Obstet Ginecol. 2015;66(3):186-94. doi.org/10.18597/ rcog.23 http://www.scielo.org.co/scielo.php?pid=S0034- 74342015000300005&script=sci_abstract&tlng=es

  58. Posadas-Nava A, Moreno-Santillán A. Control de la hemorragia obstétrica mediante ligadura selectiva de las arterias uterinas. Experiencia de siete años. Ginecol Obstet Mex. 2019;87(9):576-582. https://doi.org/10.24245/gom. v87i9.2946

  59. Doumouchtsis S, Nikolopoulos K. Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review. BJOG 2013:121(4):382-388. doi: 10.1111/1471-0528.12546

  60. Doumouchtsis S. Papageorghiou A. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstetrical & Gynecological Survey 2007;62(8):540-547. doi: 10.1097/01. ogx.0000271137.81361.93

  61. Kong C, To W. Menstrual and reproductive outcomes after use of balloon tamponade for severe postpartum hemorrhage. BMC Pregnancy Childbirth 2018;18(1):451. doi: 10.1186/s12884-018-2085-6

  62. Rossi AC, Lee R. Emergency postpartum hysterectomy for uncontrolled postpartum bleeding. a systematic review. Obstet Gynecol 2010;115(3):637-644. doi: 10.1097/ aog.0b013e3181cfc007

  63. Michelet D, Ricbourg A. Emergency hysterectomy for life-threatening postpartum haemorrhage: Risk factors and psychological impact. Gynecol Obstet Fertil 2015;43(12):773-779. doi: 10.1016/j.gyobfe. 2015.10.010

  64. Revert M, Rozenberg P. Intrauterine Balloon Tamponade for Severe Postpartum Hemorrhage. Obstet Gynecol 2018;131(1):143-149. doi: 10.1097/ aog.0000000000002405

  65. Gauchotte E, De La Torre M. Impact of uterine balloon tamponade on the use of invasive procedures in severe postpartum hemorrhage. Acta Obstet Gynecol Scand 2017;96(7):877-882. doi: 10.1111/aogs.13130

  66. Anderson Lo, Peter St. M, et al. The impact of Bakri balloon tamponade on the rate of postpartum hysterectomy for uterine atony. J Matern Fetal Neonatal Med 2017;30(10):1163- 1166. DOI: 10.1080/14767058.2016.1208742

  67. Condous GS, et al. The “tamponade test” in the management of massive postpartum hemorrhage. Obstet Gynecol 2003;101(4):767-772. doi: 10.1016/s0029- 7844(03)00046-2

  68. Ahmed S, Esraa F. The safety and effectiveness of Bakri balloon in the management of postpartum hemorrhage: a systematic review. J Matern Fetal Neonatal Med 2019;1-8. DOI: 10.1080/14767058.2019.1605349

  69. Ferrazzani S, Iadarola R. Use of an intrauterine inflated catheter balloon in massive post-partum hemorrhage: A series of 52 cases. J Obstet Gynaecol Res 2014;40(6):1603- 1610. doi: 10.1111/jog.12404

  70. Laas E, Bui C. Trends in the rate of invasive procedures after the addition of the intrauterine tamponade test to a protocol for management of severe postpartum hemorrhage. American J Obstet Gynecol 2012;207(4):281.e1-281. e7. doi: 10.1016/j.ajog.2012.08.028

  71. Al-Zirqi I, Vangen S. Prevalence and risk factors of severe obstetric haemorrhage. BJOG 2008;115(10):1265- 1272. doi: 10.1111/j.1471-0528.2008.01859.x

  72. Roberts C, Ford J. Trends in adverse maternal outcomes during childbirth: a population-based study of severe maternal morbidity. BMC Pregnancy Childbirth 2009;9:7. doi: 10.1186/1471-2393-9-7

  73. Creanga AA, Berg CJ. Pregnancy-Related Mortality in the United States, 2006–2010. Obstet Gynecol 2015;125(1):5- 12. doi: 10.1097/aog.0000000000000564

  74. Zhang W-H, Alexander S. Incidence of severe pre-eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European populationbased study: the MOMS-B survey. BJOG 2005;112(1):89- 96. doi: 10.1111/j.1471-0528.2004.00303.x

  75. World Health Organization. Department of Reproductive Health and Research. Evaluating the quality of care for severe pregnancy complications The WHO near-miss approach for maternal health. https://apps.who.int/iris/bitstream/ handle/10665/44692/9789241502221_eng.pdf;jsessioni d=851AFA04F8DCFE57BC63E1FC6F826C43?sequence=1

  76. Maswime S, Buchmann E. A systematic review of maternal near miss and mortality due to postpartum hemorrhage. Int J Gynecol Obstet 2017;137(1):1-7. doi: 10.1002/ ijgo.12096

  77. Callaghan W, Kuklina E. Trends in postpartum hemorrhage: United States, 1994–2006. Am J Obstet Gynecol 2010;202(4):353.e1-353.e6. doi:10.1016/j. ajog.2010.01.011

  78. Joseph K, Rouleau J. Investigation of an increase in postpartum haemorrhage in Canada. BJOG 2007;114(6):751- 759. doi: 10.1111/j.1471-0528.2007.01316.x

  79. Knight M, Callaghan W. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009;9:55. https:// doi.org/10.1186/1471-2393-9-55

  80. Meade-Treviño P, Fernández-Lara J. Traje antichoque no neumático: una opción en el tratamiento de la paciente con hemorragia obstétrica. Ginecol Obstet Mex 2018;86(3):200- 207. https://doi.org/10.24245/gom.v86i3.1991

  81. Higgins N, Patel S. Postpartum hemorrhage revisited. Curr Opin Anaesthesiol 2019;32(3):278-284. doi: 10.1097/ aco.0000000000000717

  82. Zaidi A, Kohli R, et al. Early Use of Fibrinogen Replacement Therapy in Postpartum Hemorrhage—A Systematic Review. Transfus Med Rev 2020;34(2):101-107. DOI: 10.1016/j. tmrv.2019.12.002

  83. Welsh A, McLintock C. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2018; 48(1):12-16. doi: 10.1111/j.1479-828x.2007.00823.x

  84. Althabe F, Therrien M. Postpartum hemorrhage care bundles to improve adherence to guidelines: A WHO technical consultation. Int J Gynecol Obstet 2020;148:290-299. doi: 10.1002/ijgo.13028

  85. Arulkumaran S, Fuchtner C. Uterine balloon tamponade for the treatment of postpartum hemorrhage; a systemic review and meta-analysis –commentary. Am J Obstet Gynecol 2020;22(4):291-292. https.//doi.org/10.1016/j. ajog.2020.01.018




2020     |     www.medigraphic.com